Cargando…
Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023
Vascular reactivity experiments using isolated aortic rings have been widely used as a model for physiological and pharmacological studies since the early sixties. Here, we suggest several parameters that the researcher should pay attention to when investigating angiotensin II in their experimental...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094174/ https://www.ncbi.nlm.nih.gov/pubmed/32259102 http://dx.doi.org/10.1155/2020/3092721 |
_version_ | 1783510414090305536 |
---|---|
author | Leal, Marcos André Soares de Almeida, Thanisia Torres, João Guilherme Gastalho Campos, Luciene Cristina Vasquez, Elisardo Corral Barauna, Valério Garrone |
author_facet | Leal, Marcos André Soares de Almeida, Thanisia Torres, João Guilherme Gastalho Campos, Luciene Cristina Vasquez, Elisardo Corral Barauna, Valério Garrone |
author_sort | Leal, Marcos André Soares |
collection | PubMed |
description | Vascular reactivity experiments using isolated aortic rings have been widely used as a model for physiological and pharmacological studies since the early sixties. Here, we suggest several parameters that the researcher should pay attention to when investigating angiotensin II in their experimental models. Angiotensin II is one of the active peptides of the renin-angiotensin system and exerts its effect through the AT1 and AT2 receptors. Some studies seek to understand the effects of angiotensin II receptors at the vascular level by using vascular reactivity experiments. However, because of the large number of variations, there are only a handful of reactivity studies that seek to use this method. Thus, the objective of this study was to standardize experimental methods with angiotensin II, through vascular reactivity protocols. For this, variables such as basal tension, concentration interval, single concentration, curve concentration response, and multiple experiments using the same aortic ring were developed using the technique of vascular reactivity in an organ bath. This is the first study that has standardized the vascular reactivity protocol. In addition, we demonstrated the effects of TRV023-biased ligand of the AT1R at vascular sites. |
format | Online Article Text |
id | pubmed-7094174 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-70941742020-04-01 Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023 Leal, Marcos André Soares de Almeida, Thanisia Torres, João Guilherme Gastalho Campos, Luciene Cristina Vasquez, Elisardo Corral Barauna, Valério Garrone Adv Pharmacol Pharm Sci Research Article Vascular reactivity experiments using isolated aortic rings have been widely used as a model for physiological and pharmacological studies since the early sixties. Here, we suggest several parameters that the researcher should pay attention to when investigating angiotensin II in their experimental models. Angiotensin II is one of the active peptides of the renin-angiotensin system and exerts its effect through the AT1 and AT2 receptors. Some studies seek to understand the effects of angiotensin II receptors at the vascular level by using vascular reactivity experiments. However, because of the large number of variations, there are only a handful of reactivity studies that seek to use this method. Thus, the objective of this study was to standardize experimental methods with angiotensin II, through vascular reactivity protocols. For this, variables such as basal tension, concentration interval, single concentration, curve concentration response, and multiple experiments using the same aortic ring were developed using the technique of vascular reactivity in an organ bath. This is the first study that has standardized the vascular reactivity protocol. In addition, we demonstrated the effects of TRV023-biased ligand of the AT1R at vascular sites. Hindawi 2020-02-21 /pmc/articles/PMC7094174/ /pubmed/32259102 http://dx.doi.org/10.1155/2020/3092721 Text en Copyright © 2020 Marcos André Soares Leal et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Leal, Marcos André Soares de Almeida, Thanisia Torres, João Guilherme Gastalho Campos, Luciene Cristina Vasquez, Elisardo Corral Barauna, Valério Garrone Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023 |
title | Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023 |
title_full | Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023 |
title_fullStr | Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023 |
title_full_unstemmed | Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023 |
title_short | Physiological and Biochemical Vascular Reactivity Parameters of Angiotensin II and the Action of Biased Agonist TRV023 |
title_sort | physiological and biochemical vascular reactivity parameters of angiotensin ii and the action of biased agonist trv023 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094174/ https://www.ncbi.nlm.nih.gov/pubmed/32259102 http://dx.doi.org/10.1155/2020/3092721 |
work_keys_str_mv | AT lealmarcosandresoares physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023 AT dealmeidathanisia physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023 AT torresjoaoguilherme physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023 AT gastalhocamposlucienecristina physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023 AT vasquezelisardocorral physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023 AT baraunavaleriogarrone physiologicalandbiochemicalvascularreactivityparametersofangiotensiniiandtheactionofbiasedagonisttrv023 |